Advances in stent technologies and their effect on clinical efficacy and safety

References

• KentKMBentivoglioLGBlockPCPercutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood InstituteAm J Cardiol1982498201120206211084
   PubMed Web of Science ®Google Scholar
• ChamberlainDAFoxKAAHendersonRAJulianDGParkerDJPocockSJCoronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participantsLancet199735090764614689274581
   PubMed Web of Science ®Google Scholar
• ParisiAFFollandEDHartiganPA comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME InvestigatorsN Engl J Med1992326110161345754
   PubMed Web of Science ®Google Scholar
• FischmanDLLeonMBBaimDSA randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study InvestigatorsN Engl J Med199433184965018041414
   PubMed Web of Science ®Google Scholar
• SerruysPWde JaegerePKiemeneijFA comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study GroupN Engl J Med199433184894958041413
   PubMed Web of Science ®Google Scholar
• LemosPASerruysPWvan DomburgRTUnrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryCirculation2004109219019514691037
   PubMed Web of Science ®Google Scholar
• MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med2003349141315132314523139
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCoxDAA polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseN Engl J Med2004350322123114724301
   PubMed Web of Science ®Google Scholar
• LagerqvistBJamesSKStenestrandULindbackJNilssonTWallentinLLong-term outcomes with drug-eluting stents versus bare-metal stents in SwedenN Engl J Med2007356101009101917296822
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus-and paclitaxel-eluting coronary stentsN Engl J Med200735610998100817296824
   PubMed Web of Science ®Google Scholar
• ManiGFeldmanMDPatelDAgrawalCMCoronary stents: a materials perspectiveBiomaterials20072891689171017188349
   PubMed Web of Science ®Google Scholar
• KastratiAMehilliJDirschingerJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trialCirculation2001103232816282111401938
   PubMed Web of Science ®Google Scholar
• PacheJKastratiAMehilliJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trialJ Am Coll Cardiol20034181283128812706922
   PubMed Web of Science ®Google Scholar
• RittersmaSZde WinterRJKochKTImpact of strut thickness on late luminal loss after coronary artery stent placementAm J Cardiol200493447748014969629
   PubMed Web of Science ®Google Scholar
• KereiakesDJCoxDAHermillerJBUsefulness of a cobalt chromium coronary stent alloyAm J Cardiol200392446346612914881
   PubMed Web of Science ®Google Scholar
• O’BrienBJStinsonJSLarsenSREppihimerMJCarrollWMA platinum-chromium steel for cardiovascular stentsBiomaterials201031143755376120181394
   PubMed Web of Science ®Google Scholar
• MenownIBNoadRGarciaEJMeredithIThe platinum chromium element stent platform: from alloy, to design, to clinical practiceAdv Ther201027312914120437213
   PubMed Web of Science ®Google Scholar
• TurcoMAThe Integrity bare-metal stent made by continuous sinusoid technologyExpert Rev Med Devices20118330330621542702
   PubMed Web of Science ®Google Scholar
• KereiakesDJCannonLAFeldmanRLClinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialJ Am Coll Cardiol201056426427120493653
   PubMed Web of Science ®Google Scholar
• StoneGWTeirsteinPSMeredithITA prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trialJ Am Coll Cardiol201157161700170821470815
   PubMed Web of Science ®Google Scholar
• MortierPDe BeuleMStent design back in the picture: an engineering perspective on longitudinal stent compressionEuroIntervention20117777377521971054
   PubMed Web of Science ®Google Scholar
• OrmistonJAWebberBWebsterMWStent longitudinal integrity bench insights into a clinical problemJACC Cardiovasc Interv20114121310131722136972
   PubMed Web of Science ®Google Scholar
• OrmistonJClinical, angiographic and IVUS outcomes of the NG PROMUS clinical trial evaluating the novel Promus Premier stentPaper presented at the EuroPCR meetingMay 21–24, 2013Paris, France
   Google Scholar
• NishioSKosugaKIgakiKLong-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stentsCirculation2012125192343235322508795
   PubMed Web of Science ®Google Scholar
• TamaiHIgakiKKyoEInitial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humansCirculation2000102439940410908211
   PubMed Web of Science ®Google Scholar
• OrmistonJASerruysPWBioabsorbable coronary stentsCirc Cardiovasc Interv20092325526020031723
   PubMed Web of Science ®Google Scholar
• PendyalaLJabaraRRobinsonKChronosNPassive and active polymer coatings for intracoronary stents: novel devices to promote arterial healingJ Interv Cardiol2009221374819281521
   PubMed Web of Science ®Google Scholar
• O’BrienBCarrollWThe evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a reviewActa Biomater20095494595819111513
   PubMed Web of Science ®Google Scholar
• NebekerJRVirmaniRBennettCLHypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) projectJ Am Coll Cardiol200647117518116386683
   PubMed Web of Science ®Google Scholar
• VirmaniRGuagliumiGFarbALocalized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Circulation2004109670170514744976
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol200648119320216814667
   PubMed Web of Science ®Google Scholar
• van der GiessenWJLincoffAMSchwartzRSMarked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteriesCirculation1996947169016978840862
   PubMed Web of Science ®Google Scholar
• LewisALTolhurstLAStratfordPWAnalysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantationBiomaterials20022371697170611922473
   PubMed Web of Science ®Google Scholar
• FajadetJWijnsWLaarmanGJRandomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trialCirculation2006114879880616908773
   PubMed Web of Science ®Google Scholar
• GuagliumiGIkejimaHSirbuVImpact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions)JACC Cardiovasc Interv20114777878521777886
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med2002346231773178012050336
   PubMed Web of Science ®Google Scholar
• HeldmanAWChengLJenkinsGMPaclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosisCirculation2001103182289229511342479
   PubMed Web of Science ®Google Scholar
• FinnAVNakazawaGJonerMVascular responses to drug eluting stents: importance of delayed healingArterioscler Thromb Vasc Biol20072771500151017510464
   PubMed Web of Science ®Google Scholar
• BurkeSEKuntzRESchwartzLBZotarolimus (ABT-578) eluting stentsAdv Drug Deliv Rev200658343744616581153
   PubMed Web of Science ®Google Scholar
• ClaessenBEHenriquesJPDangasGDClinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systemsCurr Pharm Des201016364012402421208185
   PubMed Web of Science ®Google Scholar
• WaksmanRPakalaRBaffourROptimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteriesCardiovasc Revasc Med20067317918416945826
   PubMedGoogle Scholar
• FajadetJWijnsWLaarmanGJLong-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II studyEuroIntervention20106556256721044908
   PubMed Web of Science ®Google Scholar
• LeonMBMauriLPopmaJJA randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel- eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialJ Am Coll Cardiol201055654355420152559
   PubMed Web of Science ®Google Scholar
• LeonMBNikolskyECutlipDEImproved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trialJACC Cardiovasc Interv20103101043105020965463
   PubMed Web of Science ®Google Scholar
• KandzariDELeonMBPopmaJJComparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trialJ Am Coll Cardiol200648122440244717174180
   PubMed Web of Science ®Google Scholar
• RasmussenKMaengMKaltoftAEfficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trialLancet201037597201090109920231034
   PubMed Web of Science ®Google Scholar
• MaengMTilstedHHJensenLO3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus-and sirolimus-eluting coronary stentsJACC Cardiovasc Interv20125881281822917452
   PubMed Web of Science ®Google Scholar
• KandzariDEMauriLPopmaJJLate-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)JACC Cardiovasc Interv20114554355021596327
   PubMed Web of Science ®Google Scholar
• BrugalettaSBurzottaFSabateMZotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspectiveExpert Opin Pharmacother20091061047105819364252
   PubMed Web of Science ®Google Scholar
• BanerjeeSThe Resolute Integrity zotarolimus-eluting stent in coronary artery disease: a reviewCardiology and Therapy2013219
   Google Scholar
• BelardiJAAlbertalMIntegrity(R) coronary stent: a very limber bare-metal stentCatheter Cardiovasc Interv201178690922086779
   PubMed Web of Science ®Google Scholar
• BennettJDuboisCA novel platinum chromium everolimus-eluting stent for the treatment of coronary artery diseaseBiologics2013714915923818756
   PubMedGoogle Scholar
• VerheyeSMartinetWKockxMMSelective clearance of macrophages in atherosclerotic plaques by autophagyJ Am Coll Cardiol200749670671517291937
   PubMed Web of Science ®Google Scholar
• DingNPacettiSTangF-WGadaMRoordaWXience V stent design and rationaleJ Interv Cardiol200922s1s18s27
   Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trialEuroIntervention200511586519758878
   PubMedGoogle Scholar
• SabateMCequierAIniguezAEverolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trialLancet201238098521482149022951305
   PubMed Web of Science ®Google Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialEuro Intervention20062328629419755303
   PubMedGoogle Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA2008299161903191318430909
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWRandomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trialCirculation2009119568068619171853
   PubMed Web of Science ®Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med2010362181663167420445180
   PubMed Web of Science ®Google Scholar
• StoneGWRizviASudhirKRandomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trialJ Am Coll Cardiol2011581192521514084
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet2010375971020120920060578
   PubMed Web of Science ®Google Scholar
• SmitsPCKedhiERoyaardsKJ2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial)J Am Coll Cardiol2011581111821514083
   PubMed Web of Science ®Google Scholar
• PlanerDSmitsPCKereiakesDJComparison of everolimus-and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) TrialsJACC Cardiovasc Interv20114101104111522017936
   PubMed Web of Science ®Google Scholar
• ParkKWChaeIHLimDSEverolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trialJ Am Coll Cardiol201158181844185422018294
   PubMed Web of Science ®Google Scholar
• KaiserCGalatiusSErnePDrug-eluting versus bare-metal stents in large coronary arteriesN Engl J Med2010363242310231921080780
   PubMed Web of Science ®Google Scholar
• JensenLOThayssenPHansenHSRandomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)Circulation2012125101246125522308301
   PubMed Web of Science ®Google Scholar
• SerruysPWSilberSGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med2010363213614620554978
   PubMed Web of Science ®Google Scholar
• SilberSWindeckerSVranckxPSerruysPWinvestigators RACUnrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trialLancet201137797731241124721459430
   PubMed Web of Science ®Google Scholar
• TandjungKSenHLamMKClinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trialJ Am Coll Cardiol201361242406241623602769
   PubMed Web of Science ®Google Scholar
• von BirgelenCBasalusMWTandjungKA randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trialJ Am Coll Cardiol201259151350136122341737
   PubMed Web of Science ®Google Scholar
• DammanPAbdel-WahabMMollmannHComparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registryJ Invasive Cardiol2012241049550223043032
   PubMed Web of Science ®Google Scholar
• ParkKWLeeJMKangSHSafety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus- eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registriesJ Am Coll Cardiol201361553654423273394
   PubMed Web of Science ®Google Scholar
• PalmeriniTKirtaneAJSerruysPWStent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trialsCirc Cardiovasc Interv20125335736422668554
   PubMed Web of Science ®Google Scholar
• Boston ScientificLandmark analysis of year two data from PLATINUM Workhorse Trial demonstrates superior efficacy of PROMUS Element platinum chromium stent compared with Promus (Xience V) Stent2012 Available from: http://bostonscientific.mediaroom.com/index.php?s=24889&item=125347Accessed November 12, 2013
   Google Scholar
• von BirgelenCSenHLamMKThird-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialLancet2014383991541342324183564
   PubMed Web of Science ®Google Scholar
• ByrneRAMehilliJIijimaRA polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial versus polymer-based drug-eluting stentsEur Heart J200930892393119240066
   PubMed Web of Science ®Google Scholar
• CarrieDNEXT A prospective, randomized trial comparing Cre8, a polymer-free stent eluting sirolimus, to a paclitaxel-eluting stentPaper presented at the Transcatheter Cardiovascular Therapeutics 23rd Annual Scientific SymposiumNovember 7–11, 2011San Francisco, CA, USA
   Google Scholar
• GrubeEBIOFREEDOM: a prospective randomized trial of polymer-free bioliums a9-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseasePaper presented at at the Transcatheter Cardiovascular Therapeutics 22rd Annual Scientific SymposiumSeptember 23–25, 2010Washington, DC, USA
   Google Scholar
• StellaPRDemonstr8 randomized trial results: Cre8: reduced anti-platelet therapy with effective DESPaper presented at the EuroPCR meetingMay 21–24, 2013Paris, France
   Google Scholar
• HanYLZhangLYangLXA new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE studyEuroIntervention20128781582223171802
   PubMed Web of Science ®Google Scholar
• WindeckerSSerruysPWWandelSBiolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialLancet200837296441163117318765162
   PubMed Web of Science ®Google Scholar
• StefaniniGGKalesanBSerruysPWLong-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialLancet201137898071940194822075451
   PubMed Web of Science ®Google Scholar
• RaberLKelbaekHOstojicMEffect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trialJAMA2012308877778722910755
   PubMed Web of Science ®Google Scholar
• ChristiansenEHJensenLOThayssenPBiolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trialLancet2013381986766166923374649
   PubMed Web of Science ®Google Scholar
• SmitsPCHofmaSTogniMAbluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trialLancet2013381986765166023374650
   PubMed Web of Science ®Google Scholar
• MeredithITVerheyeSDuboisCLPrimary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stentJ Am Coll Cardiol201259151362137022341736
   PubMed Web of Science ®Google Scholar
• MeredithITVerheyeSWeissmanNJSix-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentEuroIntervention20139330831523872647
   PubMed Web of Science ®Google Scholar
• OrmistonJASerruysPWRegarEA bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialLancet2008371961689990718342684
   PubMed Web of Science ®Google Scholar
• OnumaYDudekDThuesenLFive-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB Cohort A trialJACC Cardiovasc Interv2013610999100924156961
   PubMed Web of Science ®Google Scholar
• DilettiRSerruysPWFarooqVABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study designAm Heart J2012164565466323137495
   PubMed Web of Science ®Google Scholar